Clinical trials

  • UBLITUXIMAB for Relapsing multiple sclerosis
  • MEK (1/2) inhibitor for Solid Tumors
  • AG-120 for Acute myeloid leukemia (newly diagnosed) | IDH1-mutated acute myeloid leukemia | IDH2-mutated acute myeloid leukemia
  • Adeno-associated viral vector serotype rh10 containing the human cholesterol 24-hydroxylase gene (human CYP46A1) for Huntington's disease|Early manifest Huntington's disease
  • ANITOCABTAGENE AUTOLEUCEL for Relapsed/refractory multiple myeloma
  • NORADRENALINE TARTRATE for Acute myocardial infarction with cardiogenic shock
  • KYV-101 (Anti-CD19 CAR T cells) for Primary progressive multiple sclerosis|Secondary progressive multiple sclerosis
  • TEZEPELUMAB for Progressive pulmonary fibrosis (interstitial lung disease) with eosinophilia | Idiopathic pulmonary fibrosis | Interstitial pulmonary fibrosis
  • MAGNESIUM CHLORIDE HEXAHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; CALCIUM CHLORIDE DIHYDRATE; SODIUM ACETATE TRIHYDRATE; SUCCINYLATED GELATIN for Neurosurgery
  • PEGVALIASE (pegvaliase) for Phenylketonuria
  • Brentuximab for Diffuse large B-cell lymphoma|Lymphoma
  • ADEZUNAP for Borderline personality disorder